Remedy Entertainment announced this week that it has paired for publisher 505 Games to distribute its upcoming untitled game, currently referred to as “Project 7.”
For the last decade, developer Remedy has had a nice safety net under it called Microsoft Studios. Despite being a third-party development studio, the Finland-based team has published games exclusively for Xbox and PC, including Alan Wake, Alan Wake’s American Nightmare, and Quantum Break. For their next project, Remedy is going independent again so that they can publish on PlayStation, too. That means they need someone to actually get the game distributed.
505 Games will be dropping just under $8.5 million into the development of the game, as well as providing marketing and publishing. The announcement says they’ll be doing this for both digital and retail editions, suggesting that this is a game Remedy expects to put on shelves, rather than a purely digital title.
What is “Project 7?”
Remedy describes “Project 7” as a “cinematic third-person action game set in a new Remedy-created universe.” It features “an intriguing story and a game structure offering a long-lasting experience,” as well as the “deepest game mechanics yet in a Remedy game.”
Remedy is known for its pulp, fun narratives and fun action, so this sounds like it’s right in their wheelhouse. The most interesting part of the description is the “game structure offering a long-lasting experience.” That makes me think they’re going to have some kind of procedural or Roguelike elements to the game. Game developers often bring features like these to their titles to give them a bit more longevity and to keep them from ending up back on GameStop’s shelves, so don’t be surprised if Remedy breaks away from their usual linear game structure.
Remedy isn’t offering up a release date or even year for the game, and the studio is known for taking its time finishing up titles. Without the safety of Microsoft backing them, there might be a bit more fire, but we can expect to see the game in 2018 at the very earliest.